Deciphera Pharmaceuticals, Inc. Income Tax Expense
Deciphera Pharmaceuticals, Inc. reported Income Tax Expense of $431.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2024-02-07
- Deciphera Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2017-12-31 was $0.00.
- Deciphera Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2023 was $431.00K, a 40.30% decline from fiscal 2022.
- Deciphera Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2022 was $722.00K.
- Deciphera Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2021 was $0.00.
- Deciphera Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2020 was $0.00.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|
| 2023-12-31 | $431.00K 10-K · filed 2024-02-07 | ||
| 2022-12-31 | $722.00K 10-K · filed 2024-02-07 | $0.00 10-K · filed 2023-02-07 | |
| 2021-12-31 | $0.00 10-K · filed 2024-02-07 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-02-07 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-02-08 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-02-09 | ||
| 2017-12-31 | $0.00 10-K · filed 2020-03-09 | $0.00 10-K · filed 2018-03-28 |